Iliana Ilieva

Iliana Ilieva

Auto-generated profile, based on publicly available information

Iliana Ilieva

Department of Experimental Morphology, Institute of Experimental Morphology, Pathology, and Anthropology with Museum, Bulgarian Academy of Sciences, Sofia, Bulgaria

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 July 2023 in Vaccines
Verified
Journal Article
Open access
PDF file
ISIskra Ventseslavova Sainova
Iskra Ventseslavova Sainova
VKVera Ivanova Kolyovska
Vera Ivanova Kolyovska
IIIliana Ilieva
Iliana Ilieva
TMTzvetanka Markova
Tzvetanka Markova
DDDimitrina Kirilova Dimtrova-Dikanarova
Dimitrina Kirilova Dimtrova-Dikanarova
RHRadka Hadjiolova
Radka Hadjiolova
The potential of viruses as appropriate vectors for the development of new therapeutic strategies, as well as for the design of molecular (DNA, RNA, and/or protein) vaccines via substitution of nucleotide sequences, has been proven. Among the most appropriate DNA and/or RNA fragments, members belonging to families Parvoviridae (particularly adeno-associated virus, AAV) and Poxviridae have frequently been suggested for this purpose. In previous studies, the vaccine avipoxvirus strains FK (fowl) and Dessau (pigeon) have been proven able to infect mammalian cells (as well as avian cells), and to replicate productively in a small number of them; thus, we may be able to adapt them using incubation, and in these conditions. Additionally, we have previously proved, based on AAV recombinant DNA vectors, that it is possible to transfer appropriate genes of interest via mouse embryonic stem cells (mESCs). In the current study, we develop methods for the application of the same vaccine avipoxviral strains, based on the AAV DNA genome recombinant constructs, to be used for gene transfer in cells, for the transfer of DNA and/or RNA fragments (for the suppression of unwanted viral and/or cellular genes), and for the production of molecular (DNA, RNA, and/or protein) anti-cancer and anti-viral vaccines. To this end, sub-populations of embryonic mammalian cells infected with the two forms of both vaccine avipoxviral strains were frozen in the presence of cryo-protector dimethylsulfoxide (DMSO), subsequently thawed, and re-incubated. In most cases, the titers of the intra-cellular forms of the two strains were higher than those of their extra-cellular forms. These data were explained by the probable existence of the intra-cellular forms as different sub-forms, including those integrated in the cellular genome proviruses at a given stage of the cellular infection, and suggest the possibility of transferring nucleotide (DNA and/or RNA) fragments between cellular and viral genomes; this is due to the influence of activated fusion processes on DMSO, as well as drastic temperature variations.

1 January 2024 in Clinical oncohematology
Verified
Journal Article
Open access
PDF file
IIIliana Najdenova Ilieva
Iliana Najdenova Ilieva
ISI. V. Sainova
I. V. Sainova
RTR. A. Toshkova
R. A. Toshkova
AGA. K. Georgieva
A. K. Georgieva
VNV. N. Nanev
V. N. Nanev
RTR. D. Tzoneva
R. D. Tzoneva
Aim. The goal of the current study is directed to investigate the therapeutic effect of erufosine (ЕРС3) alone, as well as in combination with doxorubicin (DOX) on the development of metastases in the testes in an experimental model of transplantable Graffi myeloid tumor (GMT) in hamsters. Materials & Methods. Experimental in vivo model of GMT in Golden Syrian hamsters was used. Animals were inoculated subcutaneously with live virus-transformed malignant cells. Testes from male tumor-bearing hamsters (TBHs), treated and non-treated with the antitumor agent erufosine alone or in combination with DOX, as well as untreated healthy controls, were subjected to morphometric and histological assays on the testicular architecture to evaluate potential antitumor/antimetastatic effects in in vivo conditions. Results. The results showed no changes in blood vessels and morphology (impaired spermatogenesis and/or metastatic changes) of the testicular tissue in TBHs treated with antitumor agents (alone or in combination) compared to control healthy animals. In contrast, in the testes of TBHs without therapy, impaired spermatogenesis and foci of metastases, as well as significant changes in testicular blood vessels were found. Conclusion. The data obtained demonstrated an antitumor/antimetastatic effect of EPC3 in the testes of hamsters in the experimental GMT model.

1 January 2004
Verified
Journal Article
Closed access
EZE Zvetkova
E Zvetkova
YSY Savov
Y Savov
YGY Gluhcheva
Y Gluhcheva
III Ilieva
I Ilieva
EBE Bichkidjieva
E Bichkidjieva
ITI Tsenov
I Tsenov

1 January 2009 in Biotechnology & Biotechnological Equipment
Verified
Journal Article
Open access
III. Ilieva
I. Ilieva
SIS. Ivanova
S. Ivanova
PTP. Tzvetkova
P. Tzvetkova
YGY. Gluhcheva
Y. Gluhcheva
Motility is one of the main biological properties of spermatozoa that distinguishes them from the other cells in the organism. Their ability to move is of significant importance for the assessment of the ejaculate's quality—main criterion for determination of a man's fertility. The investigation of the factors effecting the motility of the spermatozoa aims to determine the relationship between the physico-chemical characteristics of the sperm, the pathology of the male reproductive tract and the mature spermatozoid. The results show that the highest percentage of spermatozoa with motility without progression is found in case of sexually-transmitted infections (7.25%), immotile spermatozoa are present mainly in case of specific inflammatory processes (44.5%) of the male reproductive system. The obtained data allow determination of spermatozoa motility rating as a marker for their fertilizing ability and for evaluation of the degree of infertility. In the present study we find that the percentage of spermatozoa with the highest mobility rating in cases of vascular and congenital diseases of the male reproductive tract is 55% and 51.67% respectively